Abstract
A method for infection of lymphocytes with Moloney(Abelson) murine leukemia virus [M(A)-MuLV] is described. Only lymphoblasts obtained after stimulation of normal spleen cells by the B cell mitogen lipopolysaccharide (LPS) were satisfactory targets for virus-specific, secondary cytotoxic T lymphocytes (CTL), whereas spleen cells stimulated by the T cell mitogen concanavalin A were not. The secondary CTL response against M(A)-MuLV could be efficiently measured using M(A)-MulV-infected LPS blasts as stimulating cells for secondary in vitro restimulation and as target cells for virus-specific destruction. Cold target inhibition demonstrated virus specificity of CTL. The T cell character of the cytotoxic cells was demonstrated by their sensitivity to anti-Thy-1.2 treatment. Using syngeneic virus-infected LPS blasts as target and stimulator, CTL responses were measured with effector cells from C57BL mice of the H-2b haplotype and of recombinant haplotypes sharing either K or D alleles with H-2b. In analogy with previous studies on Moloney virus-specific CTL, it was observed that C57BL/6 (H-2b) effector cells predominantly lysed Db-compatible, virus-infected target cells; B10.A(5R), (KbDd) effector cells showed a poor CTL response ag...Continue Reading
References
Jun 1, 1975·The Journal of Experimental Medicine·G M ShearerC A Garbarino
Jan 1, 1977·Advances in Cancer Research·J P Levy, J C Leclerc
Jan 1, 1977·Immunological Reviews·E Simpson, R D Gordon
Apr 1, 1978·European Journal of Immunology·E GomardT Reme
Jan 1, 1978·Immunological Reviews·R M Zinkernagel
Nov 1, 1979·The Journal of Experimental Medicine·F Plata, F Lilly
Jan 1, 1979·Advances in Immunology·R M Zinkernagel, P C Doherty
Aug 1, 1978·The Journal of Experimental Medicine·P C DohertyB B Knowles
Jun 1, 1979·The Journal of Experimental Medicine·R B Levy, G M Shearer
Nov 1, 1979·The Journal of Experimental Medicine·H von Boehmer, W Haas
Feb 27, 1975·Nature·C D Scher, R Siegler
May 1, 1975·Journal of the National Cancer Institute·W C RaschkeH Coon
Apr 1, 1975·European Journal of Immunology·F PlataK T Brunner
Oct 1, 1977·The Journal of Experimental Medicine·E GomardJ P Levy
Aug 1, 1978·The Journal of Experimental Medicine·R M ZinkernagelJ Klein
Oct 1, 1979·Journal of Immunogenetics·G BiasiL Chieco-Bianchi
Jul 1, 1978·Cellular Immunology·J M GalamaA Vos
Mar 18, 1976·Nature·K J BlankF Lilly
Aug 15, 1976·International Journal of Cancer. Journal International Du Cancer·J CernyL M Demler
Dec 1, 1970·Virology·W P RoweJ W Hartley
Oct 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·M D SklarW P Rowe
Jul 29, 1966·Science·F H Bach, N K Voynow
Jun 1, 1980·The Journal of Experimental Medicine·E GomardJ P Lévy
Citations
Jan 1, 1983·Immunogenetics·M J StukartC J Melief
Jul 1, 1985·The Journal of Experimental Medicine·F A van der HoornH D Engers
Nov 1, 1996·The Journal of Experimental Medicine·M E van den BroekH Hengartner
Mar 28, 1998·The Journal of Experimental Medicine·F OssendorpC J Melief
Aug 22, 2000·The Journal of Experimental Medicine· van Hall TF Ossendorp
Sep 10, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Koen SchepersTon N M Schumacher
Feb 15, 1984·International Journal of Cancer. Journal International Du Cancer·M J StukartC J Melief
Jul 6, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·T van HallR Offringa
Feb 5, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·N J BeekmanF Ossendorp
Sep 1, 1994·Journal of Virology·A J SijtsC J Melief